Both pre- and post-synaptic tau colocalizes with compartment-specific biomarkers in human AD brain (30, 31, 32, 33) indicating that better characterization of the different tau species in these compartments would enable a better understanding of the missorting mechanisms that operate (34, 35). This evidence concerns the gene MAPT and Alzheimer disease.